Morgan Stanley Capital Partners Invests in US HealthConnect

October 29, 2020

Investment funds managed by Morgan Stanley Capital Partners completed an investment in US HealthConnect, partnering with founder-led management while Frank Russomano remains President and CEO. US HealthConnect is a digital medical education and engagement-data platform serving pharmaceutical, biotech, diagnostic, and device companies; the investment is intended to support platform and capability expansion.

Targets
US HealthConnect
Location
Pennsylvania, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.